Blood Cancer Therapy Now Available In Australia
The nation's youngest cancer patients have been given new hope, with a cutting-edge treatment being...
The nation's youngest cancer patients have been given new hope, with a cutting-edge treatment being...
Over the last decade, technological improvements and algorithmic learning have made rapid improvements to many...
Prescient Therapeutics Limited, a clinical stage oncology company, develops novel drugs for the treatment of...
On 11 July 2019, Prescient Therapeutics Limited (ASX: PTX) announced the commencement of a Phase 1b trial of...
Highlights: Innovative ‘basket’ study design will assess drug in multiple cancers Precision medicine approach offers...
Clinical-Stage oncology company, Prescient Therapeutics Limited (ASX: PTX) bases the foundation of its business model on the ground-breaking...
This investor centre was built by Reach Markets
©2022 Reach Markets
To stay up to date with Prescient Therapeutics news and events, please register your details.